SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
39 hedge funds and large institutions have $2.58M invested in Seelos Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 29 reducing their positions, and 50 closing their positions.
Holders
39
Holders Change
-42
Holders Change %
-51.85%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
2
Reduced
29
Closed
50
Calls
$538K
Puts
$21K
Net Calls
+$517K
Net Calls Change
+$357K
Top Buyers
Top Sellers
1 |
GJL
1
Gendell Jeffrey L
|
$155K |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$395K |
3 |
WE
3
Wealth Effects
Boston,
Massachusetts
|
$318K |
4 |
4
BlackRock
New York
|
$77.8K |
5 |
SM
5
Sabby Management
Miami Beach,
Florida
|
$0 |